Filing Flows › Cryoport (CYRX) › R&D spending
Cryoport (CYRX) R&D spending by quarter
Cryoport's R&D spending was $4.7M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $3.9M (Q1 2026) to $4.9M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $4.7M | -2% | +5% |
| Q2 2026 | $4.9M | +24% | +18% |
| Q1 2026 | $3.9M | -13% | -0.7% |
| Q4 2025 | $4.5M | -1% | — |
| Q3 2025 | $4.5M | +10% | — |
| Q2 2025 | $4.1M | +5% | — |
| Q1 2025 | $3.9M | — | — |
Q3 2026 at a glance
Cryoport, Q3 2026: revenue $50.2M (+14% year over year), operating margin -17.5%, net loss $10.9M, operating cash flow $5.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cryoport's R&D spending?
Cryoport's R&D spending was $4.7M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Cryoport's R&D spending changed?
Over the last 7 quarters it ranged from $3.9M (Q1 2026) to $4.9M (Q2 2026).